Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0001045969-02-000555
Filing Date
2002-03-29
Accepted
2002-03-29 00:00:00
Documents
4
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K405 d10k405.txt 10-K405 246550
3 TERMINATION AGREEMENT dex1029.txt EX-10.29 24418
4 CONSENT OF KPMG LLP dex23.txt EX-23 944
5 CAUTIONARY STATEMENTS dex99.txt EX-99 39691
  Complete submission text file 0001045969-02-000555.txt   313553
Mailing Address OPUS CENTER 9900 BREN ROAD EAST SUITE 300E MINNEAPOLIS MN 55343
Business Address 6300 WEST OLD SHAKOPEE RD SUITE 110 BLOOMINGTON MN 55438 6129357335
MGI PHARMA INC (Filer) CIK: 0000702131 (see all company filings)

EIN.: 411364647 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-10736 | Film No.: 02592539
SIC: 2834 Pharmaceutical Preparations